LOS ALTOS, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical...
CAMBRIDGE, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing...
RENO, Nev. and ROCKVILLE, Md., Aug. 23, 2024 /PRNewswire/ -- Melzi Surgical, a medical device company focused on providing innovative technology...
-Validation Studies Confirmed the Assay Can Detect Mpox Clade I and Clade Ib in addition to Clade II- STONY BROOK,...
First pan FGFR kinase inhibitor to be approved in the European Economic Area, for adults with unresectable or metastatic urothelial...
JUPITER, Fla., Aug. 22, 2024 /PRNewswire/ -- Having a sibling with autism spectrum disorder (ASD) can at times leave an...
The Centers for Medicare and Medicaid Services (CMS) assigned a new, unique Health Care Common Procedure Coding System (HCPCS) code...
First Solid Tumor Patient Treated with Second, Higher Dose in Phase 1/1b BP1001-A Clinical Trial Experienced Tumor Reduction and Continued...
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or the “Company”) (Nasdaq: WENA) announced the signing...
Greenville, South Carolina, Aug. 20, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) is pleased to...
PLANO, Texas, Aug. 20, 2024 /PRNewswire/ -- StaffDNA®, creator of the Digital Marketplace for Healthcare Careers®, is thrilled to announce its...
From the team behind Dr. Squatch, Jukebox offers handcrafted soaps and deodorants that mix nostalgic yet innovative scents, with natural...
Promising results with Telomir-1 Demonstrates Potential in Promoting Life Quality and Longevity in Senior DogsTAMPA, FL / ACCESSWIRE / August...
Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain...
Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through Ampligen Additional commentary published discussing the potential...
Continued progress in Phase 1/2a dose escalation for LAVA-1207, including the monotherapy arm, now enrolling in dose level 12, and...
CATALYST is a Phase 2 single-blind, placebo-controlled, proof-of-concept study in patients presenting to the emergency department More than 27,569 individuals...
STONY BROOK, NY / ACCESSWIRE / August 19, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in...
LEXINGTON, Ky., Aug. 19, 2024 /PRNewswire/ -- A new study by researchers from Weill Cornell Medicine and the epigenetic company, TruDiagnostic,...
Media Release COPENHAGEN, Denmark; August 16, 2024 Rayne Waller joins as Executive Vice President and Chief Technology OfficerBrad Bailey appointed...